180 related articles for article (PubMed ID: 32546304)
1. Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
Wei DH; Cantlon MB; Wakefield DB; Vitale MA
J Hand Surg Am; 2020 Oct; 45(10):989.e1-989.e10. PubMed ID: 32546304
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
4. Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.
Atroshi I; Nordenskjöld J; Lauritzson A; Ahlgren E; Waldau J; Waldén M
Acta Orthop; 2015 Jun; 86(3):310-5. PubMed ID: 25695745
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
7. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
8. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Nayar SK; Pfisterer D; Ingari JV
Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
[TBL] [Abstract][Full Text] [Related]
9. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Hwee YK; Park D; Vinas M; Litts C; Friedman D
Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized controlled trial comparing 1- versus 7-day manipulation following collagenase injection for dupuytren contracture.
Mickelson DT; Noland SS; Watt AJ; Kollitz KM; Vedder NB; Huang JI
J Hand Surg Am; 2014 Oct; 39(10):1933-1941.e1. PubMed ID: 25194768
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures.
David M; Smith G; Pinder R; Craigen M; Waldram M; Mishra A; Dickson D; Wu F; Brewster M
J Hand Surg Am; 2020 Dec; 45(12):1187.e1-1187.e11. PubMed ID: 32861504
[TBL] [Abstract][Full Text] [Related]
15. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures.
Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC
J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081
[TBL] [Abstract][Full Text] [Related]
16. Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.
Zarb RM; Graf AR; Talhelm JE; Stehr RC; Sanger JR; Matloub HS; Daley RA
Mil Med; 2023 Aug; 188(9-10):e2975-e2981. PubMed ID: 36928340
[TBL] [Abstract][Full Text] [Related]
17. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
18. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB
J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387
[TBL] [Abstract][Full Text] [Related]
19. Collagenase Tenotomy for Dupuytren Boutonniere.
Denkler KA; Vaughn CJ; Park KM; Hansen SL
Plast Reconstr Surg; 2021 Nov; 148(5):764e-768e. PubMed ID: 34705780
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Skin Tearing in Collagenase Treatment of Dupuytren Contractures.
Zhang D; Earp BE; Blazar P
J Hand Surg Am; 2019 Dec; 44(12):1021-1025. PubMed ID: 31420243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
